• Je něco špatně v tomto záznamu ?

Immunoengineering strategies to enhance vascularization and tissue regeneration

J. Zarubova, MM. Hasani-Sadrabadi, R. Ardehali, S. Li

. 2022 ; 184 (-) : 114233. [pub] 20220315

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, přehledy, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018494

Grantová podpora
R56 DE029157 NIDCR NIH HHS - United States
R01 HL149940 NHLBI NIH HHS - United States
R01 CA234343 NCI NIH HHS - United States

Immune cells have emerged as powerful regulators of regenerative as well as pathological processes. The vast majority of regenerative immunoengineering efforts have focused on macrophages; however, growing evidence suggests that other cells of both the innate and adaptive immune system are as important for successful revascularization and tissue repair. Moreover, spatiotemporal regulation of immune cells and their signaling have a significant impact on the regeneration speed and the extent of functional recovery. In this review, we summarize the contribution of different types of immune cells to the healing process and discuss ways to manipulate and control immune cells in favor of vascularization and tissue regeneration. In addition to cell delivery and cell-free therapies using extracellular vesicles, we discuss in situ strategies and engineering approaches to attract specific types of immune cells and modulate their phenotypes. This field is making advances to uncover the extraordinary potential of immune cells and their secretome in the regulation of vascularization and tissue remodeling. Understanding the principles of immunoregulation will help us design advanced immunoengineering platforms to harness their power for tissue regeneration.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018494
003      
CZ-PrNML
005      
20220804134815.0
007      
ta
008      
220720s2022 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.addr.2022.114233 $2 doi
035    __
$a (PubMed)35304171
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Zarubova, Jana $u Department of Bioengineering, University of California, Los Angeles, CA 90095, USA; Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Prague 14220, Czech Republic
245    10
$a Immunoengineering strategies to enhance vascularization and tissue regeneration / $c J. Zarubova, MM. Hasani-Sadrabadi, R. Ardehali, S. Li
520    9_
$a Immune cells have emerged as powerful regulators of regenerative as well as pathological processes. The vast majority of regenerative immunoengineering efforts have focused on macrophages; however, growing evidence suggests that other cells of both the innate and adaptive immune system are as important for successful revascularization and tissue repair. Moreover, spatiotemporal regulation of immune cells and their signaling have a significant impact on the regeneration speed and the extent of functional recovery. In this review, we summarize the contribution of different types of immune cells to the healing process and discuss ways to manipulate and control immune cells in favor of vascularization and tissue regeneration. In addition to cell delivery and cell-free therapies using extracellular vesicles, we discuss in situ strategies and engineering approaches to attract specific types of immune cells and modulate their phenotypes. This field is making advances to uncover the extraordinary potential of immune cells and their secretome in the regulation of vascularization and tissue remodeling. Understanding the principles of immunoregulation will help us design advanced immunoengineering platforms to harness their power for tissue regeneration.
650    _2
$a biokompatibilní materiály $7 D001672
650    _2
$a lidé $7 D006801
650    _2
$a imunita $7 D007109
650    12
$a makrofágy $7 D008264
650    12
$a hojení ran $7 D014945
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hasani-Sadrabadi, Mohammad M $u Department of Bioengineering, University of California, Los Angeles, CA 90095, USA
700    1_
$a Ardehali, Reza $u Division of Cardiology, Department of Internal Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA; Eli and Edythe Broad Stem Cell Research Center, University of California, Los Angeles, CA 90095, USA; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA
700    1_
$a Li, Song $u Department of Bioengineering, University of California, Los Angeles, CA 90095, USA; Eli and Edythe Broad Stem Cell Research Center, University of California, Los Angeles, CA 90095, USA; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. Electronic address: songli@ucla.edu
773    0_
$w MED00006623 $t Advanced drug delivery reviews $x 1872-8294 $g Roč. 184, č. - (2022), s. 114233
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35304171 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134809 $b ABA008
999    __
$a ok $b bmc $g 1822194 $s 1169737
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 184 $c - $d 114233 $e 20220315 $i 1872-8294 $m Advanced drug delivery reviews $n Adv Drug Deliv Rev $x MED00006623
GRA    __
$a R56 DE029157 $p NIDCR NIH HHS $2 United States
GRA    __
$a R01 HL149940 $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 CA234343 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20220720
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace